South-Central Minzu University | China
EARLY ACADEMIC PURSUITS:
Dr. XU-KUN DENG commenced his academic journey by obtaining a Bachelor of Science degree in PHARMACY from the Department of Pharmacy at ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE between 1990 and 1994.
In his pursuit of academic excellence, Dr. DENG furthered his studies at the School of Pharmacy, NANJING UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, from 2000 to 2006. During this period, he demonstrated exceptional dedication and prowess, earning a Ph.D. degree in TRADITIONAL CHINESE MEDICINE. His academic achievements were recognized with the prestigious QIUSHI SCHOLARSHIP in HONG KONG in 2006.
CONTRIBUTIONS AND RESEARCH FOCUS ON PHARMACOGENOMICS AND PERSONALIZED MEDICINE:
Since 2007, Dr. DENG has held the position of a PROFESSOR and POSTGRADUATE TUTOR at the School of Pharmacy, SOUTH-CENTRAL MINZU UNIVERSITY. His extensive contributions to the field encompass a broad spectrum, including PHARMACOLOGY, NATURAL MEDICINE CHEMISTRY, and CHINESE MEDICINE PROCESSING.
IMPACT AND INFLUENCE:
Dr. DENG's work holds significant impact, particularly in the realms of GASTROINTESTINAL PHARMACOLOGY and TUMOR PHARMACOLOGY. His dedication to uncovering NEW ACTIVE CONSTITUENTS of TRADITIONAL CHINESE MEDICINE underscores his commitment to advancing scientific knowledge and medical practices.
His research contributions have garnered recognition, evident in the academic world through numerous citations and acknowledgments. Dr. DENG's work has left a lasting imprint on the academic landscape, influencing fellow researchers and contributing to the collective knowledge in his areas of expertise.
LEGACY AND FUTURE CONTRIBUTIONS:
As a respected figure in his field, Dr. XU-KUN DENG's legacy is marked by a commitment to excellence and a profound impact on the understanding of Traditional Chinese Medicine. His continued dedication to research and education positions him as a beacon for future scholars and practitioners in the field. The legacy he is building promises to shape the trajectory of research in pharmacology, natural medicine chemistry, and Chinese medicine processing for years to come.
Limonin relieves TGF-β-induced hepatocyte EMT and hepatic stellate cell activation in vitro and CCl4-induced liver fibrosis in mice via upregulating Smad7 and subsequent suppression of TGF-β/Smad cascade 2022 (15)
A characterized saponin extract of Panax japonicus suppresses hepatocyte EMT and HSC activation in vitro and CCl4-provoked liver fibrosis in mice: Roles of its modulatory effects on the Akt/GSK3β/Nrf2 cascade 2021(8)